Prevention of Seasonal Affective Disorder
1 other identifier
interventional
N/A
2 countries
54
Brief Summary
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2002
Shorter than P25 for phase_3
54 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 30, 2002
CompletedFirst Posted
Study publicly available on registry
October 2, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2003
CompletedJune 4, 2015
June 1, 2015
9 months
September 30, 2002
June 2, 2015
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.
You may not qualify if:
- Patient has a current or past history of seizure disorder or brain injury.
- Patient has a history or current diagnosis of anorexia nervousa or bulimia.
- Patient has recurrent summer depression more frequently than winter depression.
- Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
- Patient has initiated psychotherapy within the last 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
Study Sites (54)
Study Site
Homer, Alaska, 99603, United States
Study Site
New Haven, Connecticut, 06504-0605, United States
Study Site
Newark, Delaware, 19713, United States
Study Site
Wilmington, Delaware, 19808-1251, United States
Study Site
Washington D.C., District of Columbia, 20016, United States
Study Site
Washington D.C., District of Columbia, 20037, United States
Study Site
Boise, Idaho, 83704, United States
Study SIte
Chicago, Illinois, 60610, United States
Study Site
Chicago, Illinois, 60612, United States
Study Site
Hoffman Estates, Illinois, 60194, United States
Study Site
Libertyville, Illinois, 60048, United States
Study SIte
Northfield, Illinois, 60093, United States
Study Site
Schaumburg, Illinois, 60194, United States
Study SIte
Greenwood, Indiana, 46143, United States
Study Site
Indianapolis, Indiana, 45202, United States
Study Site
Florence, Kentucky, 41042, United States
Study Site
Wellesley Hills, Massachusetts, 02481, United States
Study Site
Okemos, Michigan, 48864, United States
Study Site
Royal Oak, Michigan, 48067, United States
Study Site
Minneapolis, Minnesota, 55454, United States
Study Site
Moorestown, New Jersey, 08057, United States
Study Site
Piscataway, New Jersey, 08854, United States
Study Site
Amityville, New York, 11701, United States
Study Site
Lawrence, New York, 11559, United States
Study Site
New York, New York, 10021, United States
Study Site
Olean, New York, 14760, United States
Study Site
Staten Island, New York, 10305, United States
Study Site
Williamsville, New York, 14221, United States
Study Site
Cincinnati, Ohio, 45219, United States
Study Site
Cleveland, Ohio, 44106, United States
Study Site
Cleveland, Ohio, 44121, United States
Study Site
Independence, Ohio, 44131, United States
Study Site
Lyndhurst, Ohio, 44124, United States
Study Site
Toledo, Ohio, 43623, United States
Study Site
Eugene, Oregon, 97401, United States
Study Site
Portland, Oregon, 97201, United States
Study Site
Portland, Oregon, 97209, United States
Study Site
Salem, Oregon, 97309, United States
Study Site
Allentown, Pennsylvania, 18104, United States
Study Site
Philadelphia, Pennsylvania, 19106, United States
Study Site
Philadelphia, Pennsylvania, 19107, United States
Study Site
Lincoln, Rhode Island, 02865-4208, United States
Study Site
Seattle, Washington, 98104, United States
Study Site
Madison, Wisconsin, 53719, United States
Study Site
Middleton, Wisconsin, 53562, United States
Study Site
Milwaukee, Wisconsin, 53226, United States
Study Site
West Allis, Wisconsin, 53227, United States
Study Site
Edmonton, Alberta, T6G 2C8, Canada
Study Site
Vancouver, British Columbia, V6Z 1Y6, Canada
Study Site
Miramichi, New Brunswick, E1V 3G5, Canada
Study Site
Sydney, Nova Scotia, B1S 2E8, Canada
Study Site
Markham, Ontario, L6B 1A1, Canada
Study Site
Mississauga, Ontario, L4W 1N2, Canada
Study Site
Hull, Quebec, J9A 1K7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 30, 2002
First Posted
October 2, 2002
Study Start
September 1, 2002
Primary Completion
June 1, 2003
Study Completion
June 1, 2003
Last Updated
June 4, 2015
Record last verified: 2015-06